According to IMARC Group, the global oral proteins and peptides market, valued at USD 1.8 Billion in 2024, is forecasted to grow to USD 3.4 Billion by 2033, exhibiting a CAGR of 7.13% from 2025 to 2033. North America dominated the market with a 97.8% share in 2024. This growth is attributed to advancements in drug delivery technologies and a growing preference for non-invasive treatme... https://www.imarcgroup.com/oral-proteins-peptides-market